References
- Khorasani G, Kosaryan M, Vahidshahi K, et al. Results of the national program for prevention of β-thalassemia major in the Iranian Province of Mazandaran. Hemoglobin. 2008;32(3):263–271.
- Dissayabutra T, Tosukhowong P, Seksan P. The benefits of vitamin C and vitamin E in children with β-thalassemia with high oxidative stress. J Med Assoc Thai. 2005;88(Suppl 4):S317–S321.
- Porter JB, Shah FT. Iron overload in thalassemia and related conditions: Therapeutic goals and assessment of response to chelation therapies. Hematol Oncol Clin North Am. 2010;24(6):1109–1130.
- Waldmeier F, Bruin GJ, Glaenzel U, et al. Pharmacokinetics, metabolism, and disposition of deferasirox in β-thalassemic patients with transfusion-dependent iron overload who are at pharmacokinetic steady state. Drug Metab Dispos. 2010;38(5):808–816.
- Lee SH, Gupta MK, Bang JB, et al. Current progress in reactive oxygen species (ROS) responsive materials for biomedical applications. Adv Healthc Mater. 2013;2(6):908–915.
- De Luca C, Filosa A, Grandinetti M, et al. Blood antioxidant status and urinary levels of catecholamine metabolites in β-thalassemia. Free Radic Res. 1999;30(6):453–462.
- Elalfy MS, Saber MM, Adly AA, et al. Role of vitamin C as an adjuvant therapy to different iron chelators in young β thalassemia major patients: Efficacy and safety in relation to tissue iron overload. Eur J Haematol. 2016;96(3):318–326.
- Sherief LM, Abd El-Salam SM, Kamal NM, et al. Nutritional biomarkers in children and adolescents with β-thalassemia-major: An Egyptian center experience. Biomed Res Int. 2014;2014:261761 doi: 10.1155/2014/261761
- Brewer C, Otto-Duessel M, Lykkesfeldt J, et al. Ascorbate status modulates reticuloendothelial iron stores and response to deferasirox iron chelation in ascorbate-deficient rats. Exp Hematol. 2012;40(10):820–827.
- Freedman MH. Management of β-thalassemia major using transfusions and iron chelation with deferoxamine. Transfus Med Rev. 1988;2(3):161–175.
- Cook JD, Reddy MB. Effect of ascorbic acid intake on nonheme-iron absorption from a complete diet. Am J Clin Nutr. 2001;73(1):93–98.
- Emara A, El Kelany R, Moustafa K. Comparative study of the protective effect between deferoxamine and deferiprone on chronic iron overload induced cardiotoxicity in rats. Hum Exp Toxicol. 2006;25(7):375–385.
- Olivieri NF, Brittenham GM. Iron-chelating therapy and the treatment of thalassemia. Blood. 1997;89(3):739–761.